Ultrafiltration volume assessment and incidence of intradialytic hypotension in patients with acute kidney injury: Comparison between bioimpedance spectroscopy technique and clinical assessment

Ultrafiltration volume assessment and incidence of intradialytic hypotension in patients with acute kidney injury: Comparison between bioimpedance spectroscopy technique and clinical assessment (UVAS-BECCA trial)

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

TCTR

Registry ID

TCTR20171117002

Enrollment

110

Registered

2017-11-17

Start date

2017-07-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intradialytic hypotension during intermittent hemodialysis in patients with acute kidney injury Intradialytic hypotension Acute hemodialysis Acute kidney injury

Interventions

Assessment of fluid removal during the first hemodialysis session by using clinical data&#44

physical examination&#44

and clinical judgement of an assessor,Assessment of fluid removal during the first hemodialysis session by using bioimpedance spectroscopy

Experimental Procedure/Surgery,Active Comparator Procedure/Surgery

Assessment of fluid removal by clinical assessment,Assessment of fluid removal by bioimpedance spectroscopy

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients age of more than 18 years 2. Patients with acute kidney injury diagnosed by the Kidney DIsease Outcome Global Initiative (KDIGO) Acute Kidney Injury Guideline 3. Patients who needs treatment with intermittent hemodialysis 4. Patients with systolic blood pressure of more than 90 mmHg and diastolic blood pressure of more than 60 mmHg measured at least 2 times between 15 and 30 minute interval 5. Patients or relatives are able to give informed consent

Exclusion criteria

Exclusion criteria: 1. Patients who do not have at least 1 extremity 2. Patients with moderate ascites 3. Patients who have implantable cardioverter defibrillator, cardiac pacemaker, or stents or metallic suture material in the heart or major arteries 4. Patients who undergone hemodialysis during the past 3 months 5. Pregnancy women 6. End-stage renal disease patients

Design outcomes

Primary

Measure	Time frame
Incidence of intradialystic hypotension in the first hemodialysis session During first hemodialysis session Change of blood pressure	—

Secondary

Measure	Time frame
Mortality rate In-hospital and at 3 months after the first hemodialysis session Percentage of patients who died,Recovery of renal function In-hospital and at 3 months after the first hemodialysis session Independence from renal replacement therapy of any mdalities,Incidence of intradialystic hypotension in subsequent hemodialysis session Subsequent hemodialysis session Change of blood pressure	—

Countries

Thailand

Contacts

Public ContactKajohnsak Noppakun

Chiang Mai University

kajohnsak.noppakun@cmu.ac.th66-81-595-3465

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026